Ecuador's Health Ministry confirmed Thursday that the South American country was going through a dengue epidemic.

India experiences the world’s absolute burden of at least 11 NTDs, including hookworm, dengue, lymphatic filariasis, leprosy, ...

Why is there still no dengue vaccine in the country?” This was the question posed by Union of Local Authorities of the Philippines president and Quirino governor Dax Cua to the Department of Health, a ...

The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion of Takeda GmbH’s live, attenuated dengue tetravalent vaccine, Qdenga ...

Sanofi's problems represent an opportunity for Takeda, which has its own own Dengue vaccine candidate in phase 3 trials. Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm ...

WHO clears Takeda's dengue vaccine May 15, 2024 The U.S. Food & Drug Administration has extended its review of Ascendis Pharma's therapy to treat adult patients with a hormone disorder by three ...

The company plans to launch its Dengue vaccine in India by 2026 and expand its focus on inflammation, oncology, and rare conditions. Japanese pharmaceutical company Takeda inaugurated its first ...

Takeda shares are available as American ... a treatment for adults with colon or rectal cancer, and Qdenga, a vaccine against dengue fever, grew at double-digit rates and now represented nearly ...